Correction to Organometallic Iridium (III) Anticancer Complexes with

Addition, Retraction, Correction pubs.acs.org/acschemicalbiology

Terms of Use

Correction to Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis Jessica M. Hearn, Isolda Romero-Canelon, Bushra Qamar, Zhe Liu, Ian Hands-Portman, and Peter J. Sadler* ACS Chem. Biol. 2013, 8(6), 1335−1343. DOI: 10.1021/cb400070a The caption for Figure 5 in the original publication incorrectly stated that data for complexes 1−4 were shown. It should refer only to data for complex 1. The corrected caption reads as follows: Figure 5. Bar graph showing the mitochondrial membrane polarization, determined by a reduction in red (FL2) fluorescence, by complex 1 against that of a negative and positive control (5 μM carbonyl cyanide m-chlorophenylhydrazone). p-values were calculated after a Welch t test with the negative control data. Each value is the mean taken from 3 replicates, with error bars for the standard deviation.

Published: October 3, 2013 © 2013 American Chemical Society

2345

dx.doi.org/10.1021/cb400715w | ACS Chem. Biol. 2013, 8, 2345−2345